1Currie LM. Cryopreservation of single-donor platelets with reduced dimethyl sulfoxide concentration by the addition of second-messenger effctors: enhanced rentention of in vitro functional activity. Transfusion, 1998,38(2): 150.
2Currie LM. Enhanced circulatory parameters of human platelets cryopreserved with second messenger effectors: an in vivo study of 16 volunteer platelet donors. Br J Haematol, 1999,105(3):826.
3Pedrazzoli P. Transfusion of platelet concentrates cryopreserved with Thrombosol plus low-dose dimethylsulphoxide in patients with severe thrombocytopenia: a pilot study. Br J Haematol,2000,108(3) :653.
4Currie LM, Harper JR, Allan H, et al. Inhibition of cytokine accumulation and bacterial growth during storage of platelet concentrates at 4℃ with rentention of in vitro functional activity. Transfusion, 1997,37(1) :18.
5Rivera J. Quality assessment of platelet concentrates supplemented with second-messenger effctors. Transfusion, 1999,39(2):135.
6Lozano ML, Rivera J, Corral J, et al. Platelet cryopreservation using a reduced dimethyl sulfoxide concentration and secondmessenger effctors as cryopreserving solution. Cryobiology,1999,39(1) :1.
7Lozano M. Effects of addition of second-messenger effctors to platelet concentrates separated from whole-blood donations and stored at 4℃ or -80℃. Transfusion,2000,40(5) :527.
8Vadhan RS. Enhanced retention of vitro functional activity of platelets from recombinant human thrombopoietin-treated patients following long-term cryopreservation with a platelet-preserving solution(Thrombosol)and 2％ DMSO. Br J Haematol,1999,104(2) :403.
9Wood EM. Prevention of monocyte adhesion and inflammatory cytokine production during blood platelet storage: an in vitro model with implications for transfusion practice. J Biomed Mater Res,2000,51 (2): 147.
10Ferrer F. Effect of cold-storage on the accumulation of bioreactive substances in platelet concentrates treated with second messenger effectors. Haematologica,2001,86(5) :530.
